LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹101 Cr | ₹101 Cr | ₹90 Cr | ₹88 Cr | ₹84 Cr |
What is the latest Total Liabilities ratio of LACTOSE (INDIA) ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹101 Cr |
Mar2023 | ₹101 Cr |
Mar2022 | ₹90 Cr |
Mar2021 | ₹88 Cr |
Mar2020 | ₹84 Cr |
How is Total Liabilities of LACTOSE (INDIA) Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹101 Cr | -0.54 | |
Mar2023 | ₹101 Cr | 12.27 | |
Mar2022 | ₹90 Cr | 2.13 | |
Mar2021 | ₹88 Cr | 5.17 | |
Mar2020 | ₹84 Cr | - |
Compare Total Liabilities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹216.0 Cr | -9.4% | -14.8% | 56.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | -9.4% |
-14.8% |
56.8% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses